Obstetric haemorrhage is a leading cause of maternal death and the most common contributor to serious obstetric morbidity. Maternal mortality audit data suggest that appropriate preparation and good emergency management leads to improved outcome. The aim of this study was to assess facilities relevant to major obstetric haemorrhage management in all units in Australia and New Zealand that offer operative obstetric services. The questionnaire was divided into ten sections : demographics, facilities, staffing, policies and guidelines, drugs, procedures, equipment, point of care testing, availability of O negative blood and free comments. Responses were received from 240 (76.4%) of the 314 hospitals surveyed (187 public and 53 private). One hundred and nine units (45%) had fewer than 500 deliveries per year. Distances to referral facilities were frequently very large. Of the 90 hospitals (38.1%) without an onsite blood bank, 12 did not have a supply of blood for emergencies. Half of all units (n=121) had on-site intensive care or high dependency facilities and 72.9% (n=175) had an on-site cardiac arrest team. Only 58.8% of units (n=141) had a written haemorrhage protocol. Findings are presented in the context of other literature, including evidence-based guidelines. Haemorrhage responds well to appropriate treatment, although careful preparation and anticipation of problems is required. In our region geographical factors and different systems of healthcare complicate provision of obstetric services. Where facilities are limited, women should be offered antenatal transfer to a larger centre.
Obstetric haemorrhage remains a leading cause of maternal death worldwide and national audit projects show that good preparation and improved management can lead to better outcomes 1, 2 . Furthermore, haemorrhage appears to be the most common contributor to serious obstetric morbidity 3, 4 . Provision for obstetric haemorrhage has not been previously investigated in our region. This survey of all obstetric units that provide operative services in Australia and New Zealand was designed to obtain current information on facilities relevant to the management of major haemorrhage.
MATERIALS AND METHODS
After obtaining ethics clearance, a confidential postal questionnaire was sent to all operative obstetric units in Australia and New Zealand. The questionnaire was divided into ten sections: demographics, facilities, staffing, policies and guidelines, drugs, procedures, equipment, point of care testing, availability of O negative blood and space for free comments (see Appendix).
The survey was addressed to the lead Obstetric Anaesthetist/Director of Anaesthesia or individuals if known. All public or private facilities performing planned operative deliveries were included. These units were identified using the Australian Hospitals Directory 2003 5 and New Zealand Index of Hospital Specialties 6 , supplemented by information from the Australian Bureau of Statistics 7 , Australian Institute of Health and Welfare 8 , Australian State Health Departments and as a result of telephone calls to individual units for clarification. Hospitals with fewer than 50 deliveries per year and military hospitals were excluded from the study. Hospitals treating both public and private patients were classified as public units. The study was conducted between May and November 2003. Two reminders were sent to nonresponders at three-monthly intervals. Data were entered into a Microsoft Access database. Percentage figures relate to the total number of hospitals responding to the question concerned. It is intended that the survey and commentary will be distributed to all respondents.
RESULTS

Response rate and demographics
Responses were received from 265 (78.1%) of the 339 hospitals surveyed. Twenty-five hospitals did not have an operative obstetric service, leaving 240 of 314 units for analysis (net response rate 76.4%; Table  1 ). Only one private hospital was identified in New Zealand and was analysed with the other New Zealand units. Around two-thirds of responding hospitals had fewer than 1000 deliveries/year, although 13 hospitals (5.4%) had more than 4000 deliveries/year ( Figure  1 ). to all units, a lesser proportion of Australian private hospitals had on-site blood bank or haematology facilities, and a greater proportion of New Zealand units had an on-site ICU. Quantities of O negative blood stored on-site in hospitals without an on-site blood bank are shown in Figure 4 . Twelve hospitals without on-site blood bank facilities did not have O negative blood available. Distances to facilities are shown in Figure 5 . Ninety-one of 159 hospitals (57.2%) that were not referral units had a system of antenatal haemorrhage risk assessment and referral of high risk patients in place. A greater proportion of New Zealand hospitals (n=9; 32%) than Australian hospitals (n=17; 8%) had a dedicated obstetric theatre facility.
Facilities on-site
Staffing
There were large variations in anaesthetic and obstetric staffing arrangements ( Figure 6 ). All hospitals without specialists available were peripheral and small (<500 deliveries/year), except one unit (1000-1999 deliveries/year). Of other specialties, general and/or vascular surgeons were rostered on call in 122 units (50.8%). In addition, a haematologist was rostered on call or available for telephone consultation in 232 units (96.7%).
Delivery unit policies and guidelines
Written major haemorrhage protocols and some form of audit, such as the Anaesthesia Incident Monitoring Study (AIMS) were in place at 58.8% (n=141) and 68.3% (n=164) of hospitals respectively. Fewer units had a list of problems requiring anaesthetic consultation (29.6%; n=71) or had arranged major haemorrhage 'drills' (14.6%; n=36). No New Zealand hospital had practised such a drill ( Figure 7 ).
Drugs
Availability of drugs relevant to haemorrhage management in the delivery suite was as follows: prostaglandins, 214 delivery units (89.2%), antifibrinolytics, n=120 (50%), ketamine, n=128 (53.3%), calcium, n=196 (81.6%) and vasopressin, n=114 (47.5%).
Other procedures
Availability of other techniques relevant to major haemorrhage management is shown in Figure 8 . Few units had incorporated these techniques into obstetric protocols.
Equipment
With respect to equipment relevant to major haemorrhage management, 101 units (42.6%) had a dedicated haemorrhage trolley in the hospital, although almost all (99.1%) had a resuscitation/ defibrillation trolley ( Figure 9 ). Equipment was more often stored elsewhere (e.g. main operating theatres) than in delivery suite.
Point of care testing
With respect to 'bedside' testing, 200 hospitals (83.3%) stated that they could measure haemoglobin. Other techniques available included arterial blood gas analysis (n=187; 77.9%), activated partial thromboplastin time (APTT) or activated clotting time (ACT; n=166; 69.1%) and calcium assay (n=160; 66.6%). Ten hospitals (4.2%) had a thrombo-elastograph (TEG), although none indicated use in the obstetric setting.
Other information
Most units (n=214; 92%) reserved intravenous (IV) Figure 9 : Equipment according to obstetric unit size. cannulation for patients with epidurals, operative cases and other high risk groups, however all women in labour received an IV cannula in 18 units. Most units (n=167; 77%) performed haematology investigations (complete blood count or group and antibody screen) only in higher risk or operative cases.
Comments
Free text comments were received from 73/240 units (30%). Some provided details of local facilities and arrangements (including protocols), while others documented concern regarding inadequate resources and staffing, low morale and poor communication.
DISCUSSION
The current survey confirms that significant variation exists in facilities for major obstetric haemorrhage management in our region. There are many small obstetric units providing operative services, both because of a very large geographical area and the availability of private maternity care. Distances to referral facilities were frequently very large.
Maternal mortality and morbidity caused by haemorrhage
The Report on Maternal Deaths in Australia for the 1997-1999 triennium was published in August 2004 2 . There were eight deaths from haemorrhage and this was the most common direct cause of death. All of these cases were catastrophic postpartum haemorrhages. In the latest report from the United Kingdom, 'Why Mothers Die 2000-2002' 1 , obstetric haemorrhage was the second most common direct cause of death, representing a dramatic increase in ranking from previous triennia 10 . Substandard care in the setting of obstetric haemorrhage was generally multifactorial, including women known to be at higher risk of complications being delivered in isolated maternity units 1 . Recommendations echoed previous reports ( Table 2) .
Although postpartum haemorrhage (PPH) of 500-1000 ml is generally well tolerated, haemorrhage in excess of 1000 ml must be treated without delay 11 and the degree of blood loss is commonly underesti-mated 12 . In a large series, Stones reported a 1.3% incidence of PPH greater than 1000 ml within 24 hours of delivery 13 . Observation of such cases should ideally be in a high dependency environment.
In a recent Australian study the incidence of caesarean hysterectomy related to PPH was 1 in 2000 deliveries. The authors highlighted the increase in rate of emergency caesarean hysterectomy over the last decade and suggested a link with repeat caesarean sections and subsequent abnormal placental implantation 14 . This is consistent with the observation in 'Why Mothers Die 2000-2002', that all four women who died from haemorrhage related to placenta praevia had had a previous caesarean section 1 .
Death is now such a rare complication of pregnancy in the developed world that its value as a quality assurance indicator has been questioned 15 . Consequently, interest in severe obstetric morbidity or 'near miss' events that describe 'the rest of the iceberg' has developed. This type of data could be used to allocate resources and measure improvement in care more precisely than mortality data. However, implementation of recommendations from mortality audit is likely to benefit far more women than an improvement in mortality figures might suggests.
In the largest 'near miss' study reported to date, involving 51,165 deliveries in Scotland 3 , 'near miss' occurred in 3.8 per 1000 deliveries and the severe morbidity to mortality ratio was 49:1. As in a previous large United Kingdom study, haemorrhage accounted for half the severe morbidity 16 . Haemorrhage may also be the most common reason for obstetric intensive care admission 4 . Delay in diagnosis and treatment of surgical bleeding, coagulopathy and hypovolaemia are the most important preventable factors 1 . Fortunately, most of these generally fit, young women appear to recover fully (in contrast to the catastrophic outcomes of amniotic fluid embolism syndrome and thromboembolism) 17, 18 . Major obstetric haemorrhage may be viewed as a critical incident, where risk factors such as pre-eclampsia, multiple pregnancy and previous caesarean section 16, 19 lead to predicted and unpredicted scenarios. Although ideally suited to 'dress rehearsals' using patient simulation 20 , just 15% of hospitals in the current study had rehearsed obstetric haemorrhage scenarios. Antenatal risk assessment and referral should ideally be formalized, but only just over half the peripheral hospitals in this survey had such a system in place.
Guidelines for obstetric anaesthesia services
This appears to be the first regional survey of facilities and there are no local standards published for prevention and management of major obstetric haemorrhage, so comparison over time or against a prescribed standard is not possible. However, a Joint Colleges Position Statement on the Provision of Obstetric Anaesthesia Services in Australia and New Zealand is currently being developed 21 . This draft document states that 'maternity units should be adequately staffed and resourced to allow timely access' to protocols, emergency assistance (including intensive care), blood supplies, laboratory testing, haematology advice, operating theatres and neonatology services. Furthermore, where obstetric and anaesthetic services offered by an institution are limited, women should be informed of this and offered antenatal transfer to a larger centre. Specific recommendations relevant to major haemorrhage have been published in the United Kingdom and the United States (Table 2) .
Clinical practice guidelines provide an evidencebased template which can be modified, taking into account local circumstances (e.g. distance from blood bank and transport considerations). These are not intended as standards but should be supportive of usual practice and aim to 'bring in the outliers' 25 . The Scottish Obstetric Guidelines and Audit Project (SOGAP) 26 has developed practice guidelines for management of postpartum haemorrhage (PPH) which draw on Confidential Enquiries into Maternal Deaths and other sources and are relevant to all obstetric haemorrhage. A quick reference guide, table of risk factors, guidelines for women refusing blood transfusion and a dataset for local audit are included. Other published guidelines follow a similar pattern 27 and several survey respondents sent details of excellent local haemorrhage protocols/guidelines based on these publications including a framework for management of PPH circulated by the NSW State Health Department 28 .
The Scottish Confidential Audit of Severe Maternal Morbidity is a pioneering initiative where local clinical risk management teams assess overall quality of care in cases of severe obstetric haemorrhage and formulate an action plan with the goal of generating lessons for the whole country 29 . The project had assessed 133 cases at the time of publication of 'Why Mothers Die 2000-2002'. It is planned that the results of the current Australasian Survey will be distributed to all respondents.
Comparison with previous studies
Few studies of obstetric facilities have been published elsewhere. In 1994, Hibbard and Milner audited the implementation of recommendations of the Confidential Enquiries into Maternal Deaths in 248 public obstetric units in the United Kingdom 30 . Results from the survey suggest that now 10, years later, facilities in our region trail behind (see Figure  10 ). Comparison must acknowledge the huge geographical differences and presence of private maternity care in Australia. However, several deficiencies in the region are apparent. Only 59% of units had a written haemorrhage protocol and of the 82 hospitals in the current study without an on-site blood bank, twelve (14.6%) did not appear to have an emergency supply of O negative red blood cells. Availability of blood for transfusion is essential for safe obstetric practice. In addition, only 50% of hospitals had HDU or ICU facilities available. This may reflect referral patterns and demography (for example, seriously ill women are more likely to be treated on-site in the United Kingdom).
Bouvier-Collé and colleagues investigated factors associated with substandard management of severe obstetric haemorrhage in France 31 . After adjusting for other factors, smaller unit size (less than 500 deliveries/year) and lack of 24 hour on-site anaesthetist were the only factors associated with substandard care. There was a non-significant trend towards improved care with availability of a local blood bank, haemorrhage guidelines, on-site ICU and 24 hour on-site obstetrician.
Newer technologies
The use of autologous techniques including predonation, acute normovolaemic haemodilution (ANH) and cell savers in obstetric practice is contentious [32] [33] [34] . In Australia and New Zealand, where bank blood is demonstrably very safe, uptake of these techniques is likely to be low, and although available few units had utilized autologous transfusion for obstetric patients. ANH may have been confused with fluid preloading by some respondents.
One respondent stated that recombinant factor VIIa (rVIIa) had been used successfully in several obstetric patients and was included in local guidelines. rVIIa appears to be an effective haemostatic agent in difficult clinical scenarios involving haemorrhagerelated coagulopathy 35 , including in obstetrics 36 . The risk of significant thrombotic complications appears to be low. The use of TEG in obstetric cases has been reviewed 37 , but no hospital in Australasia indicated that it was being utilized. The use of both rVIIa and TEG in severe obstetric haemorrhage is worthy of continued evaluation.
Critique of methods
The census population was optimized by using multiple data sources and covering letter assured anonymity. Two reminders were sent to nonresponders, and in view of the sensitive and detailed nature of the questionnaire, the response rate of 76.4% appears acceptable. A limitation was reliance on selfreporting, with no opportunity to probe responses or perform site visits. It is possible that there was non-response bias (with centres failing to respond having poorer facilities) although, judging from free comments, respondents experiencing frustration with resources were well represented (volunteer effect). It is possible these sources of biases may have effectively balanced each other. No conclusions can be drawn regarding availability of drugs and other procedures in the hospital, because the question posed related to availability in delivery suite. Bedside testing appeared to have been misinterpreted as laboratory testing by some respondents. Overall, however, the survey results are likely to reasonably reflect current facility levels.
CONCLUSION
Haemorrhage responds well to appropriate treatment, although careful preparation and anticipation of problems is required. In our region geographical factors and the parallel systems of healthcare complicate the provision of obstetric services. Although there are a large number of small obstetric units, frequently isolated and with limited resources, maternal mortality rates in Australia and New Zealand are at least as good as those of other developed countries. With improvement in planning to deal with serious obstetric morbidity, even better mortality rates may be attainable. In each unit, equipment, training and haemorrhage protocols tailored to the unique set of circumstances on-site must be available. Some form of near miss reporting and analysis is recommended, including implementation and review processes. When considering the viability of an obstetric service, issues of safety and economics should be balanced with convenience and maternal choice in low risk pregnancy. If facilities are limited, women should be in a position to make an informed decision regarding their antenatal transfer to a larger centre.
